Find a Trial

Trial Summary


Protocol No.PHO-NOVARTIS-CCTL019G2201J
StatusOPEN TO ACCRUAL
Principal InvestigatorSkiles, Jodi
ScopeNational
PhasePhase II
Age GroupChildren
TitleA phase II trial of tisagenlecleucel in first-line high-risk (HR) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (B-ALL) who are minimal residual disease (MRD) positive at the end of consolidation (EOC) therapy
Applicable Disease SitesLeukemia, other
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactCourtney B. Spiegel, Phone: +1 317-948-0581
    Pager:
    Email: clorch@iu.edu